HALO logo
halo search icon
ANI Pharmaceuticals, Inc.

US$82.77

Price Change Indicator
0.77 (0.939%)
ANI Pharmaceuticals, Inc.
ANIP · NAS

ANI Pharmaceuticals, Inc.

Start Trading ANIP for Free

US$82.77

Price Arrow0.77 (0.939%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO Capital EfficiencyHALO Earnings MomentumHALO GARPHALO Growth+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ANI Pharmaceuticals, Inc. Overview

ANIP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About ANIP

icon
icon

Telephone

1.218.634.3500

icon

Address

210 Main Street West, Baudette, MN 56623

Description

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANIP Price Chart

Key Stats

Market Cap

US$1.86B

PE

23.70

EV/EBITDA

11.6

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 56.71 - 99.5

Trade Value (12mth)

US$8,208,781.00

1 week

5.11%

1 month

2.32%

YTD

4.55%

1 year

43.18%

All time high

392.04

Key Fundamentals

EPS 3 yr Growth

-215.00%

EBITDA Margin

19.50%

Operating Cashflow

$185m

Free Cash Flow Return

16.90%

ROIC

6.50%

Interest Coverage

5.30

Quick Ratio

2.20

Other Data

Shares Outstanding (Fully Diluted)

22m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ANIP Announcements

Latest Announcements

DateAnnouncements
22 May 26
22 May 26
13 May 26
13 May 26
08 May 26

ANIP Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.95-1.043.5locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.94-1.043.32locklocklock
Growth
 %locklocklocklock131.3-209.4435.8locklocklock
PE
 Xlocklocklocklock58.5N/A23.7locklocklock
EV/EBITDA
 Xlocklocklocklock1022.411.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of ANI Pharmaceuticals, Inc. (ANIP:NAS)?
Halo FAQ
The current share price of ANI Pharmaceuticals, Inc. (ANIP:NAS) is USD$82.77.
What is the 52-week high share price for ANI Pharmaceuticals, Inc. (ANIP:NAS)?
Halo FAQ
The 52-week high share price for ANI Pharmaceuticals, Inc. (ANIP:NAS) is USD$99.50.
What is the 52-week low share price for ANI Pharmaceuticals, Inc. (ANIP:NAS)?
Halo FAQ
The 52-week low share price for ANI Pharmaceuticals, Inc. (ANIP:NAS) is USD$56.71.
What is the dividend yield for ANI Pharmaceuticals, Inc. (ANIP:NAS)?
Halo FAQ
ANI Pharmaceuticals, Inc. (ANIP:NAS) does not pay a dividend.
What was ANI Pharmaceuticals, Inc. (ANIP:NAS) last dividend payment?
Halo FAQ
ANI Pharmaceuticals, Inc. (ANIP:NAS) does not pay a dividend.
What is the franking level for ANI Pharmaceuticals, Inc. (ANIP:NAS)?
Halo FAQ
ANI Pharmaceuticals, Inc. (ANIP:NAS) has a franking level of 0.00%.
In which sector is ANI Pharmaceuticals, Inc. (ANIP:NAS) classified?
Halo FAQ
ANI Pharmaceuticals, Inc. (ANIP:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for ANI Pharmaceuticals, Inc. (ANIP:NAS)?
Halo FAQ
The current P/E ratio for ANI Pharmaceuticals, Inc. (ANIP:NAS) is 23.70.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial